Houston Methodist 13th Annual Houston Methodist Cancer Symposium 2025

Description Include: 9 videos 1 pdf, size: 4.06 GB Target Audience: practicing oncologists, medical, surgical, and radiation oncologists Sample video: contact me for sample video Information: Event starts:  08/15/2025 – 8:00am CDT Event ends: 08/15/2025 – 5:00pm CDT This annual symposium, dedicated to the science and clinical care of solid and hematologic malignancies, brings together Houston Methodist scientists and physicians from a broad spectrum of fields, including basic, clinical, and epidemiological research. A wide range of topics will be covered, from innovative translational science to clinical updates with strategies for implementation in current clinical practice. The program will provide education focused on improving patient care, research collaboration and leading medicine. Target Audience Physician scientists, practicing oncologists, physician assistants, advanced nurse practitioners, oncology nurses, residents, fellows, medical students, allied health care professionals and clinical research associates will benefit from this course. Learning Objectives At the conclusion of this activity, the participant should be able to: Discuss the fundamental mechanisms of cellular immunotherapy in hematologic malignancies Describe the approved cell therapy options in hematologic malignancies including CAR-T cell Identify new cellular therapies in the pipeline for these diseases The Houston Methodist 13th Annual Cancer Symposium (2025) is best for clinicians, researchers, and care teams seeking state-of-the-art updates spanning solid and hematologic malignancies, with a practical focus on translating innovations into current practice. Who should attend Medical, surgical, and radiation oncologists: Evidence-based updates and implementation strategies across tumor types Pathologists and radiologists: Translational science that impacts diagnostics and treatment planning Hematologists and bone marrow transplant teams: Advances in hematologic malignancies and supportive care Nurses, pharmacists, and advanced practice providers: Multiprofessional perspectives and clinical takeaways for daily care Researchers and trainees: Opportunities to present abstracts and engage with cutting-edge cancer science What you’ll learn Innovative translational science: From bench discoveries to bedside applications in oncology Clinical updates: Strategies for integrating new evidence into treatment pathways for solid and hematologic cancers Outcomes-focused practice: Content designed to enhance competency and real-world patient care   Topics: 13th Annual Houston Methodist Cancer Symposium August 15, 2025 Time Presentation Speaker 7:30 AM Registration 8:20 AM Welcome 8:30 AM Oncology Keynote: Developing Innovative Therapy Lawrence Einhorn, MD 9:15 AM Question and Answer Session 9:25 AM Renal Cell Carcinoma State of Research: Accomplishments and Future Directions Nizar Tannir, MD, FACP 9:55 AM Question and Answer Session 10:00 AM Break and Exhibits 10:25 AM Advances in the Management of Metastatic Castration Sensitive Prostate Cancer: What the Future Holds Jorge Garcia, MD, MSc, FACP 10:55 AM Question and Answer Session 11:00 AM Integrating Cardiometabolic Risk Stratification into Cancer Care Sadeer Al – Kindi, MD, FACC 11:30 AM Question and Answer Session 11:35 AM Lunch Keynote I: CAR T Therapy: Milestones in Cancer Immunotherapy and New Horizons in Targeting PSMA Bin He, PhD 12:05 PM Lunch Keynote II: Trauma Informed Care in Oncology Jessica Blanc, MSW, LCSW 12:35 PM Lunch and Exhibits 1:00 PM AI foundation models in the front of biomedicine Guangyu Wang, PhD 1:45 PM Question and Answer Session 1:55 PM AI in Healthcare: Enhancing Diagnosis and Decision-Making Sunil Mathur, PhD 2:25 PM Question and Answer Session 2:30 PM Break and Exhibits 2:45 PM Current and Future Technologies and Artificial Itelligence in Diagnostic Hematopathology John Rogers, MD 3:15 PM Question and Answer Session 3:20 PM Break and Exhibits 3:50 PM Abstract Winner Discussions 4:30 PM Question and Answer Session 4:45 PM Adjournment